FdaApplication
ANDA 202327
Identifiers
- fda_app_no: ANDA202327
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
| approval_date | 2025-12-30 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | EQ 25MG BASE | TABLET;ORAL |
| SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | EQ 100MG BASE | TABLET;ORAL |
| SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | EQ 50MG BASE | TABLET;ORAL |
3 products